HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -81.8% | 12,049 | -62.3% | 0.00% | -50.0% |
| Q4 2019 | $22,000 | -4.3% | 31,991 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | -55.8% | 35,037 | +12.6% | 0.00% | -33.3% |
| Q2 2019 | $52,000 | -36.6% | 31,122 | -3.3% | 0.00% | -25.0% |
| Q4 2018 | $82,000 | -61.9% | 32,191 | -24.5% | 0.00% | -69.2% |
| Q3 2018 | $215,000 | -24.3% | 42,664 | -45.6% | 0.01% | -13.3% |
| Q1 2018 | $284,000 | +165.4% | 78,360 | +24.0% | 0.02% | +200.0% |
| Q3 2017 | $107,000 | – | 63,172 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,675,889 | $6,797,000 | 5.97% |
| PERKINS CAPITAL MANAGEMENT INC | 449,950 | $1,143,000 | 0.89% |
| Diametric Capital, LP | 116,754 | $297,000 | 0.23% |
| Granahan Investment Management | 924,300 | $2,348,000 | 0.17% |
| Requisite Energy Fund I LP | 100,000 | $254,000 | 0.10% |
| Requisite Capital Management, LLC | 100,000 | $254,000 | 0.10% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $635,000 | 0.09% |
| Kalos Management, Inc. | 74,420 | $179,000 | 0.09% |
| Crow Point Partners, LLC | 65,475 | $164,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 35,000 | $89,000 | 0.02% |